← Back to Markets

LIMN

Liminatus Pharma Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$0.18$-0.00 (-1.13%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for LIMN is being prepared.

Key Stats

Key Stats

Open

$0.18

Day High

$0.19

Day Low

$0.17

Prev Close

$0.19

Volume

0

Avg Volume

961.5K

Day Change

$-0.00

Change %

-1.13%

Fundamentals

Fundamentals

EPS (TTM)

$-0.20

Market Cap

$8M

52-Wk Range

$0.16 — $33.66

Earnings History

Insider Activity

Who Owns This Stock

Who Owns LIMN

Passive / Index47.8%3 holders
Other23.7%5 holders
Tactical / Macro22.4%1 holder
Dealer / Bank6.1%3 holders

Based on Q4 2025 13F filings + AC behavioral model

12 institutional holders

Top Holders

1.Citadel Advisors
$43.3B
2.Geode Capital Management
+2.3%$34.0B
3.Vanguard Group
+119.5%$30.8B
4.TWO SIGMA INVESTMENTS, LP
$21.5B
5.Vanguard Group
0.0%$14.0B
6.UBS Group AG
$11.6B
7.State Street
$11.6B
8.BlackRock, Inc.
0.0%$8.1B
9.TWO SIGMA SECURITIES, LLC
$7.2B
10.Geode Capital Management
-82.8%$5.7B
11.Tower Research Capital LLC (TRC)
$5.4B
12.UBS Group AG
-65.6%$184M
13.Bank of America Corp
+2.6%$24M
14.Farther Finance Advisors, LLC
0.0%$19M
15.Bank of America Corp
-86.8%$3M
16.Citigroup Inc
$1M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Moderate Selling Pressure
Passive / Index(47.8%)
Holds
Other(23.7%)
Tactical / Macro(22.4%)
Reducing rapidly
Dealer / Bank(6.1%)
Facilitating

48% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Inst. Flows10 increased/new, 3 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of LIMN on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.